Incidental Mutation 'R4438:Acvr1'
ID 329604
Institutional Source Beutler Lab
Gene Symbol Acvr1
Ensembl Gene ENSMUSG00000026836
Gene Name activin A receptor, type 1
Synonyms Alk8, Tsk7L, SKR1, D330013D15Rik, ActRIA, ALK2, Acvr1a, Acvr, Alk-2, Acvrlk2, ActR-I
MMRRC Submission 041703-MU
Accession Numbers
Essential gene? Essential (E-score: 1.000) question?
Stock # R4438 (G1)
Quality Score 225
Status Validated
Chromosome 2
Chromosomal Location 58336450-58456840 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to A at 58367739 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Isoleucine to Phenylalanine at position 141 (I141F)
Ref Sequence ENSEMBL: ENSMUSP00000108220 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000056376] [ENSMUST00000090935] [ENSMUST00000112599] [ENSMUST00000112601] [ENSMUST00000126407]
AlphaFold P37172
Predicted Effect probably benign
Transcript: ENSMUST00000056376
AA Change: I141F

PolyPhen 2 Score 0.003 (Sensitivity: 0.98; Specificity: 0.44)
SMART Domains Protein: ENSMUSP00000056784
Gene: ENSMUSG00000026836
AA Change: I141F

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably benign
Transcript: ENSMUST00000090935
AA Change: I141F

PolyPhen 2 Score 0.003 (Sensitivity: 0.98; Specificity: 0.44)
SMART Domains Protein: ENSMUSP00000088453
Gene: ENSMUSG00000026836
AA Change: I141F

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably benign
Transcript: ENSMUST00000112599
AA Change: I141F

PolyPhen 2 Score 0.003 (Sensitivity: 0.98; Specificity: 0.44)
SMART Domains Protein: ENSMUSP00000108218
Gene: ENSMUSG00000026836
AA Change: I141F

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 1.4e-13 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably benign
Transcript: ENSMUST00000112601
AA Change: I141F

PolyPhen 2 Score 0.003 (Sensitivity: 0.98; Specificity: 0.44)
SMART Domains Protein: ENSMUSP00000108220
Gene: ENSMUSG00000026836
AA Change: I141F

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 4e-14 PFAM
transmembrane domain 124 146 N/A INTRINSIC
GS 178 208 5.13e-16 SMART
Blast:STYKc 212 501 1e-25 BLAST
Predicted Effect probably benign
Transcript: ENSMUST00000126407
SMART Domains Protein: ENSMUSP00000120755
Gene: ENSMUSG00000026836

DomainStartEndE-ValueType
signal peptide 1 23 N/A INTRINSIC
Pfam:Activin_recp 33 107 3.9e-15 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000145495
Meta Mutation Damage Score 0.0898 question?
Coding Region Coverage
  • 1x: 99.2%
  • 3x: 98.5%
  • 10x: 97.0%
  • 20x: 94.7%
Validation Efficiency 100% (52/52)
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. This gene encodes activin A type I receptor which signals a particular transcriptional response in concert with activin type II receptors. Mutations in this gene are associated with fibrodysplasia ossificans progressive. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous inactivation of this gene leads to embryonic growth arrest and complete embryonic lethality due to gastrulation defects associated with abnormalities in primitive streak formation, embryonic epiblast morphology, and mesoderm and ectoderm development. [provided by MGI curators]
Allele List at MGI

All alleles(12) : Targeted, knock-out(4) Targeted, other(3) Gene trapped(5)

Other mutations in this stock
Total: 47 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
Adam6b A C 12: 113,454,281 (GRCm39) Q366P probably damaging Het
Adck1 C T 12: 88,397,920 (GRCm39) Q185* probably null Het
Adgrb3 T C 1: 25,870,108 (GRCm39) probably benign Het
Als2cl T C 9: 110,714,466 (GRCm39) S105P probably damaging Het
Asns C A 6: 7,675,320 (GRCm39) A561S probably benign Het
Bcl2a1d A T 9: 88,613,753 (GRCm39) M7K probably benign Het
Bst1 A T 5: 43,982,682 (GRCm39) probably null Het
Cdc37l1 T C 19: 28,985,021 (GRCm39) F224L probably damaging Het
Csmd3 G A 15: 47,763,191 (GRCm39) T1215I possibly damaging Het
Csnk1e A T 15: 79,305,129 (GRCm39) S323T probably benign Het
Cyp2j7 G T 4: 96,105,646 (GRCm39) T288K probably benign Het
Dnaaf5 T A 5: 139,149,147 (GRCm39) I482N probably damaging Het
Dpy19l3 A G 7: 35,392,284 (GRCm39) I636T probably damaging Het
Enpep T G 3: 129,077,740 (GRCm39) T626P possibly damaging Het
Fgfr2 G A 7: 129,774,660 (GRCm39) R509* probably null Het
Gm5849 T A 3: 90,685,182 (GRCm39) K1M probably null Het
Gpr83 T C 9: 14,776,134 (GRCm39) Y152H probably damaging Het
Hdac7 T C 15: 97,705,596 (GRCm39) E400G probably damaging Het
Hypk A T 2: 121,288,475 (GRCm39) E82V probably damaging Het
Iqub C A 6: 24,505,867 (GRCm39) A14S probably benign Het
Lias T C 5: 65,552,787 (GRCm39) M130T probably damaging Het
Lingo4 T C 3: 94,310,204 (GRCm39) S381P possibly damaging Het
Mdn1 A G 4: 32,704,635 (GRCm39) T1536A probably damaging Het
Moxd2 T A 6: 40,860,996 (GRCm39) D265V probably damaging Het
Mtbp C A 15: 55,466,611 (GRCm39) S541R probably benign Het
Or10j27 C A 1: 172,957,869 (GRCm39) C305F probably benign Het
Or2a54 T C 6: 43,093,221 (GRCm39) S182P probably benign Het
Or4k15b T C 14: 50,272,287 (GRCm39) D191G probably damaging Het
Pcsk9 G T 4: 106,316,156 (GRCm39) Q96K probably benign Het
Pramel14 T C 4: 143,718,192 (GRCm39) Y417C probably damaging Het
Rln1 A T 19: 29,311,962 (GRCm39) F12Y possibly damaging Het
Setd1a A G 7: 127,384,903 (GRCm39) N585D possibly damaging Het
Siah1b G A X: 162,854,688 (GRCm39) P131S probably damaging Het
Smarcal1 T C 1: 72,650,637 (GRCm39) probably benign Het
Snx19 G T 9: 30,339,895 (GRCm39) L344F probably benign Het
Srfbp1 T C 18: 52,621,403 (GRCm39) C155R probably benign Het
Sspo C T 6: 48,464,287 (GRCm39) R3914C probably damaging Het
Tacc2 G A 7: 130,225,271 (GRCm39) S652N probably damaging Het
Tmub1 A C 5: 24,651,068 (GRCm39) L197R probably damaging Het
Tnc T C 4: 63,926,066 (GRCm39) T905A possibly damaging Het
Tnfrsf21 G T 17: 43,398,733 (GRCm39) R613L possibly damaging Het
Ugt3a1 A T 15: 9,351,283 (GRCm39) E97D probably benign Het
Vmn2r25 A G 6: 123,816,756 (GRCm39) I275T probably benign Het
Zfp1010 T G 2: 176,956,889 (GRCm39) Q203P possibly damaging Het
Zfp568 G T 7: 29,721,721 (GRCm39) C221F probably benign Het
Zfp91 C A 19: 12,755,385 (GRCm39) E217* probably null Het
Zswim3 T A 2: 164,662,563 (GRCm39) C348S probably benign Het
Other mutations in Acvr1
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00691:Acvr1 APN 2 58,337,585 (GRCm39) missense probably benign 0.00
IGL01392:Acvr1 APN 2 58,390,558 (GRCm39) missense probably benign 0.01
IGL01526:Acvr1 APN 2 58,348,997 (GRCm39) missense probably benign 0.20
IGL02524:Acvr1 APN 2 58,338,319 (GRCm39) splice site probably benign
IGL02682:Acvr1 APN 2 58,367,823 (GRCm39) missense probably benign 0.00
IGL02795:Acvr1 APN 2 58,352,964 (GRCm39) missense probably damaging 1.00
R0084:Acvr1 UTSW 2 58,348,895 (GRCm39) critical splice donor site probably null
R0452:Acvr1 UTSW 2 58,390,507 (GRCm39) missense probably benign 0.13
R0746:Acvr1 UTSW 2 58,390,562 (GRCm39) start codon destroyed probably null 0.01
R1484:Acvr1 UTSW 2 58,369,901 (GRCm39) missense probably damaging 1.00
R1514:Acvr1 UTSW 2 58,337,597 (GRCm39) nonsense probably null
R1645:Acvr1 UTSW 2 58,352,911 (GRCm39) missense probably damaging 1.00
R1925:Acvr1 UTSW 2 58,337,661 (GRCm39) missense probably damaging 0.99
R2435:Acvr1 UTSW 2 58,369,704 (GRCm39) missense probably damaging 1.00
R2873:Acvr1 UTSW 2 58,367,808 (GRCm39) nonsense probably null
R3729:Acvr1 UTSW 2 58,352,925 (GRCm39) missense probably null 0.09
R3854:Acvr1 UTSW 2 58,352,946 (GRCm39) missense probably damaging 1.00
R4863:Acvr1 UTSW 2 58,367,723 (GRCm39) missense possibly damaging 0.60
R5543:Acvr1 UTSW 2 58,353,157 (GRCm39) missense probably damaging 1.00
R5558:Acvr1 UTSW 2 58,349,029 (GRCm39) missense probably damaging 1.00
R5618:Acvr1 UTSW 2 58,352,955 (GRCm39) missense probably damaging 1.00
R6233:Acvr1 UTSW 2 58,338,411 (GRCm39) missense probably benign 0.04
R6236:Acvr1 UTSW 2 58,367,678 (GRCm39) missense probably benign 0.17
R6565:Acvr1 UTSW 2 58,369,769 (GRCm39) missense probably damaging 1.00
R6912:Acvr1 UTSW 2 58,337,585 (GRCm39) missense probably benign 0.00
R7739:Acvr1 UTSW 2 58,352,983 (GRCm39) missense possibly damaging 0.47
R7912:Acvr1 UTSW 2 58,364,230 (GRCm39) missense probably damaging 0.97
R8127:Acvr1 UTSW 2 58,367,638 (GRCm39) missense probably benign 0.14
R8343:Acvr1 UTSW 2 58,364,286 (GRCm39) critical splice acceptor site probably null
R8688:Acvr1 UTSW 2 58,352,961 (GRCm39) missense probably damaging 0.98
R8876:Acvr1 UTSW 2 58,338,422 (GRCm39) missense possibly damaging 0.83
R9135:Acvr1 UTSW 2 58,352,983 (GRCm39) missense possibly damaging 0.47
R9290:Acvr1 UTSW 2 58,338,330 (GRCm39) missense probably damaging 1.00
R9562:Acvr1 UTSW 2 58,338,385 (GRCm39) missense probably damaging 1.00
R9565:Acvr1 UTSW 2 58,338,385 (GRCm39) missense probably damaging 1.00
Z1176:Acvr1 UTSW 2 58,369,880 (GRCm39) missense probably benign 0.00
Predicted Primers PCR Primer
(F):5'- TGACTAGTCACCATACATGTCTGC -3'
(R):5'- TCGGGATCAGGAGCCATTAC -3'

Sequencing Primer
(F):5'- AGTCACCATACATGTCTGCATAGTC -3'
(R):5'- CAGGAGCCATTACCTAAGATATTGG -3'
Posted On 2015-07-21